GMO Benchmark-Free Allocation stands apart from peers as a pure expression of the firm’s valuation-focused investment philosophy. An expert duo backed by robust resources shepherds the strategy, but the unconstrained approach can face unique challenges.
GMO Benchmark-Free Allocation Fund Class R6 GBMSX
- NAV / 1-Day Return 33.46 / −0.18 %
- Total Assets 2.6B
-
Adj. Expense Ratio
1.350%
- Expense Ratio 0.670%
- Distribution Fee Level High
- Share Class Type Retirement, Large
- Category Global Moderate Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity High/Limited
- Status Open
- TTM Yield 3.84%
- Turnover 11%
USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:11 AM GMT+0
Morningstar’s Analysis GBMSX
Will GBMSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 48.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Us 2yr Note (Cbt) | 34.11 | 838M | Government |
Contra Derivatives - Swaps | 22.99 | 565M | — |
Us 5yr Note (Cbt) | 13.46 | 331M | Government |
United States Treasury Notes 3.77% | 12.01 | 295M | Government |
10 Year Treasury Note Future June 26 | 7.57 | 186M | Government |
United States Treasury Notes 3.86% | 5.89 | 145M | Government |
Ultra 10 Year US Treasury Note Future June 26 | 4.95 | 122M | Government |
United States Treasury Notes 3.83% | 4.86 | 119M | Government |
Future on TOPIX | −3.58 | −88M | — |
Contra Derivatives - Futures | −54.21 | −1B | — |
United States